Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine versus remifentanil for bleeding control during endoscopic nasal surgery
2011-005965-18Phase 4Completed
- Sponsor
- Fundació Parc Taulí
- Start
- Jan 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clonidine and remifentanil in rhinosinusitis and chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Fundació Parc Taulí. Primary endpoint: Surgical field bleeding by modified Boezaart scale. Started Jan 2012; status: completed.
02
Drugs
clonidineremifentanil
03
Conditions
rhinosinusitischronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on 2011-005965-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005965-18.